Rimini Street Certified as a Tier 1 Vendor in Israel for Application Support Outsourcing
Rimini Street, Inc. , a global provider of enterprise software services, and the leading independent support provider for Oracle® and SAP® products, today announced that leading Israeli analyst firm STKI has certified the Company as a Tier 1 vendor in the Application Support Outsourcing space. The Company was also recognized as the market’s Fastest-Growing IT Vendor. Rimini Street’s strong growth and momentum in the region is due to high demand from Oracle and SAP licensees for its unique premium-level software support. SKTI awarded the certification to Rimini Street at its annual STKI Summit 2017. Rimini Street is the only enterprise software support provider for Oracle and SAP products to receive this certification.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170613005150/en/
“We have been tracking Rimini Street since the Company first entered Israel two years ago, and are impressed with how quickly Israeli organizations have chosen to adopt its independent software support model over the vendors’ support,” said Dr. Jimmy Schwarzkoph, research fellow and managing partner, STKI. “The Company’s size, pace of growth, value proposition, go-to-market strategy, and management team are all factors we considered when reviewing this Tier 1 vendor certification, and Rimini Street scored off-the-charts in all areas. CIOs and IT leaders who are looking to maximize the sizeable investment made in their stable ERP system, should consider making the switch to Rimini Street.”
“We are honored to be certified by STKI as a Tier 1 vendor for Application Support Outsourcing in the Israeli market; this recognition underscores our passion for, and commitment to, delivering ultra-responsive service for an organization’s mission-critical core ERP,” said Jack Oster , general manager of Israel and Eastern Europe, Rimini Street. “We continue to see demand from the C-suite and IT leaders across this dynamic region, who are challenged with optimizing their IT spend while at the same time are looking to shift investment to more strategic initiatives to help grow their business and gain a competitive edge.”
Rimini Street opened its Tel Aviv office in 2015, and today services more than 80 global organizations with operations in Israel and Eastern Europe, including five of the 10 largest Israeli companies in the region.
Founded in 1992, STKI is the leading market research and strategic analyst firm in Israel, covering IT infrastructure, applications and services. Customers include major organizations in the government, financial, telecoms, manufacturing, medical and education industries. The Company’s mission is to advise and analyze users of information technology as well as their suppliers, while conducting original research and providing advisory services regarding all aspects of the information system puzzle.
About Rimini Street, Inc.
Rimini Street is the global leader in providing independent enterprise software support services. The company has redefined enterprise support services since 2005 with an innovative, award-winning program that enables licensees of Oracle, SAP, IBM®, Microsoft® and other enterprise software vendors to save up to 90 percent on total support costs. Clients can remain on their current software release without any required upgrades for a minimum of 15 years. Nearly 1,300 global Fortune 500, midmarket, public sector and other organizations from a broad range of industries currently rely on Rimini Street as their trusted, independent support provider. To learn more, please visit http://www.riministreet.com , follow @riministreet on Twitter and find Rimini Street on Facebook and LinkedIn .
This press release may contain forward-looking statements. The words “believe,” “may,” “will,” “plan,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are subject to risks and uncertainties, and are based on various assumptions. If the risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. Rimini Street assumes no obligation to update any forward-looking statements or information, which speak only as of the date of this press release.
© 2017 Rimini Street, Inc. All rights reserved. “Rimini Street” is a registered trademark of Rimini Street, Inc. in the United States and other countries, and Rimini Street, the Rimini Street logo, and combinations thereof, and other marks marked by TM are trademarks of Rimini Street, Inc. All other trademarks remain the property of their respective owners, and unless otherwise specified, Rimini Street claims no affiliation, endorsement, or association with any such trademark holder or other companies referenced herein.
Rimini Street, Inc.
Michelle McGlocklin, +1 925 523-8414
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
ELLIOTT-MANAGEMENT-CORP23.3.2018 17:07 | pressemeddelelse
Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:54 | pressemeddelelse
Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe
CO-CLOVIS-ONCOLOGY-INC23.3.2018 13:52 | pressemeddelelse
CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets
JANSSEN23.3.2018 13:48 | pressemeddelelse
Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)
AITHEON23.3.2018 13:02 | pressemeddelelse
Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai
VIIV-HEALTHCARE23.3.2018 12:29 | pressemeddelelse
ViiV Healthcare Gains CHMP Positive Opinion for Juluca (dolutegravir/rilpivirine) in Europe
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum